Huajie Xu
180 Fenglin Road
Shanghai, 200032, China
Shanghai, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Calcitriol Suppresses Platelet Activation and Thrombosis, Mitigating Cardiovascular Risks in Metabolic Dysfunction-Associated Steatotic Liver Disease.
Journal: JACC. Basic to translational science
Published: January 08, 2026
Hyperspectral Imaging-Based Deep Learning Method for Detecting Quarantine Diseases in Apples.
Journal: Foods (Basel, Switzerland)
Published: August 25, 2025
Thrombotic risk trajectories in patients with coronary artery disease before and during COVID-19.
Journal: iScience
Published: August 12, 2025
Recognition of Wood-Boring Insect Creeping Signals Based on Residual Denoising Vision Network.
Journal: Sensors (Basel, Switzerland)
Published: July 22, 2025
Thyroid-stimulating hormone enhances platelet activation and arterial thrombosis.
Journal: Cardiovascular research
Published: May 23, 2025
Indobufen Versus Aspirin Plus Clopidogrel in Patients After Coronary Stenting in Patients With Diabetes: A Post Hoc Analysis of the OPTION Trial.
Journal: Journal of diabetes
Published: April 29, 2025
ALDH2 rs671 variant enhances platelet activation and thrombosis by disrupting mitochondrial complex I assembly.
Journal: Cardiovascular research
Published: April 17, 2025
The soluble guanylate cyclase (sGC) stimulator vericiguat inhibits platelet activation and thrombosis.
Journal: European journal of pharmacology
Published: December 10, 2024
Indobufen-based dual antiplatelet therapy in patients with multivessel coronary disease undergoing drug-eluting stent implantation insight from the OPTION trial.
Journal: American heart journal
Published: October 11, 2024
Fetuin-A increases thrombosis risk in non-alcoholic fatty liver disease by binding to TLR-4 on platelets.
Journal: Cardiovascular research
Published: September 23, 2024
Last Updated: 09/26/2026